Research demonstrates exosomes from bone marrow mesenchymal stem cells repress pulmonary fibrosis via microRNA-31-5p targeting IGFBP7.
Key Points
Exosomes from bone marrow mesenchymal stem cells mitigate the effects of pulmonary fibrosis in mice, improving lung function and reducing inflammation.
After bleomycin treatment, mice had elevated levels of inflammation markers—such as TNF-α, IL-1β, and IL-6, indicating significant lung damage and fibrosis.
Analysis involved assessing the relationship between microRNA-31-5p and IGFBP7, demonstrating that miR-31-5p targets IGFBP7 to exert its effects on fibrosis.
IGFBP7 overexpression counteracts the beneficial effects of miR-31-5p, highlighting its critical role in the progression of pulmonary fibrosis.